O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.3B
AUM Growth
+$10.3B
(+13%)
Cap. Flow
+$348M
Cap. Flow
% of AUM
3.38%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
137
New
10
Increased
53
Reduced
17
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$103M |
| 2 |
SIEN
Sientra, Inc.
SIEN
|
$53.5M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$49.5M |
| 4 |
MGLN
Magellan Health Services, Inc.
MGLN
|
$48.3M |
| 5 |
Gilead Sciences
GILD
|
$45.9M |
Top Sells
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
$215M |
| 2 |
Arrowhead Research
ARWR
|
$76.5M |
| 3 |
STJ
St Jude Medical
STJ
|
$55.3M |
| 4 |
QGENF
QIAGEN NV
QGENF
|
$38.7M |
| 5 |
OraSure Technologies
OSUR
|
$34.4M |
Sector Composition
| 1 | Healthcare | 87.22% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XNPT
51
DELISTED
XENOPORT, INC.
XNPT
| $48.6M | 0.46% | 5,546,100 | – | – |
|
52
Puma Biotechnology
PBYI
$254M
| $47.5M | 0.45% | 250,900 +38,000 | +18% | +$7.19M |
|
53
Cerus
CERS
$251M
| $43.9M | 0.42% | 7,035,000 -150,000 | -2% | -$936K |
|
|
CLVS
54
DELISTED
Clovis Oncology, Inc.
CLVS
| $40M | 0.38% | +714,100 | New | +$40M |
|
55
ProQR Therapeutics
PRQR
$237M
| $39.6M | 0.38% | 1,829,400 +879,400 | +93% | +$19.1M |
|
|
ISEE
56
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $38.7M | 0.37% | 861,800 +523,000 | +154% | +$23.5M |
|
57
Celldex Therapeutics
CLDX
$1.47B
| $37.6M | 0.36% | 2,062,200 -119,400 | -5% | -$2.18M |
|
|
AFMD
58
DELISTED
Affimed
AFMD
| $36.1M | 0.34% | 5,814,630 | – | – |
|
59
Medtronic
MDT
$119B
| $35.7M | 0.34% | 493,800 +70,500 | +17% | +$5.09M |
|
|
ARRY
60
DELISTED
Array Biopharma Inc
ARRY
| $34.3M | 0.33% | 7,247,700 +844,900 | +13% | +$4M |
|
61
Cardinal Health
CAH
$35.5B
| $26.2M | 0.25% | 325,000 +48,000 | +17% | +$3.88M |
|
|
LOXO
62
DELISTED
Loxo Oncology, Inc
LOXO
| $25.6M | 0.24% | 2,175,857 | – | – |
|
|
KYTH
63
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $25.1M | 0.24% | +722,900 | New | +$25.1M |
|
|
PTLA
64
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.1M | 0.23% | 850,700 | – | – |
|
65
UnitedHealth
UNH
$281B
| $23.8M | 0.23% | 235,000 +35,000 | +18% | +$3.54M |
|
66
Bausch Health
BHC
$2.74B
| $23.2M | 0.22% | 162,000 +24,000 | +17% | +$3.43M |
|
67
Teva Pharmaceuticals
TEVA
$21.1B
| $23M | 0.22% | 400,000 -262,000 | -40% | -$15.1M |
|
|
MRTX
68
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.6M | 0.21% | 1,167,000 | – | – |
|
|
COV
69
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $21.6M | 0.21% | 211,200 +30,600 | +17% | +$3.13M |
|
|
70
OraSure Technologies
OSUR
$242M
| $20.1M | 0.19% | 1,978,500 -3,393,500 | -63% | -$34.4M |
|
|
FWP
71
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $20M | 0.19% | +960,600 | New | +$20M |
|
|
AMAG
72
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $20M | 0.19% | 469,000 +311,000 | +197% | +$13.3M |
|
|
RCPT
73
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $19.1M | 0.18% | +156,100 | New | +$19.1M |
|
74
Jazz Pharmaceuticals
JAZZ
$7.75B
| $18.8M | 0.18% | 115,000 | – | – |
|
75
Elevance Health
ELV
$71.8B
| $17.4M | 0.17% | 138,800 +20,300 | +17% | +$2.55M |
|